drugset
drugset / Trial / NCT02277041

Carbetocin Versus Misoprostol in Cases With Placenta Previa After C.S.

NCT02277041 ↗

Phase 4 Unknown 200 enrolled Beni-Suef University Cairo University · collab
RandomizedParallel-groupTriple-blindPrevention

Summary

We will compare efficacy and safety of Carbetocin with Misoprostol in prevention of postpartum hemorrhage in Placenta previa women after C.S.

Timeline

Start
2014-10
Primary completion
2021-04
Completion
2021-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carbetocin Peptide 100 ug Intravenous
Comparator Misoprostol Other / unclassified 600 ug Rectal

Indications

No indication recorded.